Please login to the form below

hematology

This page shows the latest hematology news and features for those working in and with pharma, biotech and healthcare.

A first for Bluebird and Europe as gene therapy Zynteglo approved

The approval comes just days ahead of a number of important phase 3 read outs for Zynteglo at the European Hematology Association (EHA) congress in Amsterdam.

Latest news

J&J’s targeted bladder cancer treatment gets US approval

with advances being made in new disease types,” said Richard Pazdur, director of the FDA’s Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products
Darzalex powers ahead with frontline myeloma approval in Europe

first investigator to administer daratumumab in human trials and Professor, head of the department of hematology at Vejle Hospital, Denmark.
China’s BeiGene takes PD-1 antibody into pivotal trials

Jane Huang. , M.D., Chief Medical Officer, Hematology, at. BeiGene (pictured).
More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease

While the US-based ASCO and ASH congresses tend to get the most important haemato-oncology and blood disorder data readouts, the European Hematology Association (EHA) congress now under way in
FDA clears Dova drug for liver-related low blood platelets

Hematology and Oncology Products at the FDA.

More from news
Approximately 6 fully matching, plus 49 partially matching documents found.

Latest Intelligence

Attracting doctors to low-demand specialties

A brief glance at the programme for the major US haematology congress, held by the American Society of Hematology, tells its own story, with most sessions being dedicated to haematological malignancies
Deal Watch November 2016

This does not typically include royalty payments. 2. Ataga et al, Abstract, American Society of Hematology (ASH), December 2016.
Deal Watch July 2016

Portfolio of early-stage hematology candidates &option for recombinant pegasparaginase. Licence, option.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Nanobiotix strengthens US leadership team

Most recently, Dr Obrocea was AbbVie Biotherapeutics' project director and oncology clinical lead, overseeing a number of trials in oncology and hematology.
TxCell appoints global scientific advisory board

Prof Chiara Bonini (pictured left) is currently head of the experimental hematology unit at the San Raffaele Scientific Institute, a position she has held since 2008.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Highlights in haematologic malignancy from ASH 2018

Earlier this month, Porterhouse Medical attended the 60. th. American Society of Hematology (ASH) Annual Meeting (). The ASH congress is the most comprehensive haematology event of the year, attracting 25, 000
Random42 Attending ASH Annual Meeting in San Diego

Now in its 60th year the American Society of Hematology (ASH) annual meeting and exposition is the premier event in malignant and non-malignant hematology. ... The meeting provides an invaluable educational experience and the opportunity to review
Increasing the speed of knowledge sharing in blood cancer to improve patient care

Society of Hematology XXXVI World Congress in Congress ( ISH), which was hosted by the British Society for Haematology at the 56th Annual Scientific Meeting, between 18th-21st April.
Lighthouse Medical Communications US bolster their senior scientific team

number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’s health and rare diseases.
Attracting doctors to low-demand specialties: A role for industry?

A brief glance at the programme for the major US haematology congress, held by the American Society of Hematology, tells its own story, with most sessions being dedicated to haematological malignancies

More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....